A phase 2 randomized, double-blind, placeo-controlled study of the safety and efficacy of talactoferrin alfa in patients with severe sepsis, protocol LF-0801.

Project: Research project

Project Details

StatusActive
Effective start/end date1/1/08 → …

Funding

  • Abstracts Reporting Research -- Non-Peer Reviewed